What Academics Need to Know about Starting a Company From a Lab
Starting a company out of an academic lab may not be easy, but with the right idea and validated science, investors will come, says UTR Therapeutics CEO Chidiebere Awah, MD.
George Church, PhD, on the Future of AI-Driven Drug Discovery
George Church, PhD, who leads Synthetic Biology at Harvard University's Wyss Institute and has co-founded some 50 biotech companies, shares insights about how machine learning is dramatically transforming the speed of drug development and testing.
From Concept to Acquisition and Back Again: Building Life Sciences Startups
Serial entrepreneur and academic researcher Shana Kelley, PhD, is President of the Chan Zuckerberg Biohub Chicago and Professor of chemistry and biomedical engineering at Northwestern University. She holds 50 patents and established four startups.
What Does "Cure" Mean to Oncologist Elizabeth Comen, MD
Elizabeth Comen, MD, is a breast cancer oncologist and Associate Professor of Medicine at NYU Langone Health. She also is the author of All in Her Head: The Truth and Lies Early Medicine Taught Us About Women's Bodies and Why It Matters Today.
Cure on the Road at #BIO2024
Cure on the Road touched down in San Diego for the BIO2024 convention, asking entrepreneurs and CEOs about investing in women's health, the healthcare ecosystem and how new companies working on novel cancer innovations can work with NIH for grants.
Now Playing
What Academics Need to Know about Starting a Company From a Lab
George Church, PhD, on the Future of AI-Driven Drug Discovery
From Concept to Acquisition and Back Again: Building Life Sciences Startups
What Does "Cure" Mean to Oncologist Elizabeth Comen, MD
